Abera Bioscience plans to advance vaccine candidates and BERA platform after raising SEK 7.9 million from warrant exercise

Reuters2026/07/23 06:42

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Abera Bioscience plans to use about SEK 7.9 million in proceeds from the TO2025/2026 warrant exercise to accelerate development of its vaccine candidates and the BERA platform.
The funding is also intended to strengthen financial flexibility ahead of the next development phase.
The warrant exercise delivered 958,185 new shares at SEK 8.2 each, implying 87.7% subscription.
The new shares are set to be admitted to trading on Spotlight Stock Market once registration is completed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abera Bioscience AB published the original content used to generate this news brief on July 23, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Abera Bioscience plans to advance vaccine candidates and BERA platform after raising SEK 7.9 million from warrant exercise

You may also like

Crypto prices